Radioimmunoassay of Drugs and Neurotransmitters

  • S. Spector
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 82)


Pharmacologists pose a number of questions for themselves regarding drugs. They are interested in the role of absorption, distribution, metabolism, excretion, and localization of the compound. In order to answer these questions, it is necessary that methods be available, but these methods must also have the attributes of high sensitivity, specificity, and reproducibility. An added attribute of an assay would be if the procedure had a simplicity that neither required extraction from biologic fluids nor column chromatography nor high pressure liquid chromatography instrumentation currently available. The radioimmunoassay techniques as developed by Berson and Yalow (1959) possess most of the attributes enumerated above. However, it needs to be emphasized that the specificity of the assay is not absolute.


Succinic Anhydride Barbituric Acid Bovine Serum Albumin Solution Mixed Anhydride Sodium Nitrite Solution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aravagiri N, Hawkes EM, Midha KK (1985) Radioimmunoassay for the 7-hydroxy metabolite of trifluoperazine and its application to a kinetic study in human volunteers. J Pharmaceut Sci. 74: 1196–1202CrossRefGoogle Scholar
  2. Berkowitz BA, Ngai SH, Hempstead J, Spector S (1975) Disposition of naloxone: use of a new radioimmunoassay. J Pharmacol Exp Ther. 195: 499–504PubMedGoogle Scholar
  3. Berson SA, Yalow RS (1959) Quantitative aspects of the reaction between insulin and insulin binding antibody. J Clin Invest. 38: 1996Google Scholar
  4. Butler V (1975) Drug immunoassays. J Immunol Methods. 7: 1–24PubMedCrossRefGoogle Scholar
  5. Butler VP Jr, Smith TW, Schmidt DH, Haber E (1977) Immunological reversal of the effects of digoxin. Fed Proc. 36: 2235–2241PubMedGoogle Scholar
  6. Coppen A (1973) Role of serotonin in affective disorders. In: Barchas J, Usdin E (eds) Serotonin and behavior. Academic, New York, pp 523–527Google Scholar
  7. DeCarlo I Jr, Adler FI (1973) Neutralization of morphine activity by antibody. Res Com- mun Chem Pathol Pharmacol. 5: 775–788Google Scholar
  8. Delbarre B, Schmitt H (1971) Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol. 13: 356–363PubMedCrossRefGoogle Scholar
  9. Dixon R, Crews T (1977) An 125I radioimmunoassay for the determination of the anticonvulsant agent clonazepam directly in plasma. Res Commun Chem Pathol Pharmacol. 18: 477–486PubMedGoogle Scholar
  10. Dixon R, Crews T (1978) Diazepam determination in micro samples of blood, plasma and saliva by radioimmunoassay. J Anal Toxicol. 2: 210–213Google Scholar
  11. Dollery CT, Davies DS, Draffan GH, Dargie HJ, Dean CR, Reid JL, Clare RA, Murray S (1976) Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther. 19: 11–17PubMedGoogle Scholar
  12. Erlanger BF (1973) Principles and methods for the preparation of drug protein conjugates for immunological studies. Pharmacol Rev. 25: 271–280PubMedGoogle Scholar
  13. Erlanger BF, Borek F, Beiser S, Lieberman S (1957) Steroid protein conjugates I. Preparation and characterization of bovine serum albumin with testosterone and cortisone. J Biol Chem. 228: 713PubMedGoogle Scholar
  14. Erlanger BF, Borek F, Beiser S, Lieberman S (1959) Steroid protein conjugates II. Preparation and characterization of conjugates of bovine serum albumin with progesterone, deoxycorticosterone and estrone. J Biol Chem. 234: 1090PubMedGoogle Scholar
  15. Flynn EJ, Cerreta KY, Spector S (1977) Pharmacologic response to pentobarbital in actively immunized mice. Eur J Pharmacol. 42: 21–29PubMedCrossRefGoogle Scholar
  16. Grota LJ, Brown GM (1974) Antibodies to indolealkylamines: serotonin and melatonin. Can J Biochem. 52: 196–202PubMedGoogle Scholar
  17. Günne IM, Jonsson J, Paalzow L, Anggard E (1975) Antibody bound nalorphine released on challenge with morphine. Nature. 255: 418–419PubMedCrossRefGoogle Scholar
  18. Henderson GL, Frincke J, Leung CY, Torten M, Benjamini E (1975) Antibodies to fenta- nyl. J Pharmacol Exp Ther. 192: 489–96PubMedGoogle Scholar
  19. Horowitz P, Spector S (1973) Determination of serum d-tubocurarine concentration by radioimmunoassay. J Pharmacol Exp Ther. 184: 94–100Google Scholar
  20. Hubbard JW, Midha KK, McGilvery I J, Cooper GK (1978) Radioimmunoassay for psychotropic drugs. J Pharmaceut Sei. 67: 1563–1571CrossRefGoogle Scholar
  21. Jarrott B, Spector S (1978) Disposition of Clonidine in rats as determined by radioimmu-noassay. J Pharmacol Exp Ther. 207:195–202PubMedGoogle Scholar
  22. Kawashima K, Dixon R, Spector S (1975) Development of radioimmunoassay for chlor- promazine. Eur J Pharmacol. 32: 195–202PubMedCrossRefGoogle Scholar
  23. Kawashima K, Ishikawa H, Mochizuki M (1980) Radioimmunoassay for acetylcholine in the rat brain. J Pharmacol Methods. 2: 115–123CrossRefGoogle Scholar
  24. Kleinman JE, Biglow LB, Rogel A, Weinberger DR, Nasrallah HA, Wyatt RJ, Gillis CJ (1980) In: Usdin E, Eckert H, Forrest IS (eds) Phenothiazine and structurally related drugs: basic and clinical studies. Elsevier/North-Holland, New York, pp 275–278Google Scholar
  25. Kobinger W, Walland A (1967) Investigation into the mechanism of the hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline HCl. Eur J Pharmacol. 2: 155–162PubMedCrossRefGoogle Scholar
  26. Landsteiner K (1945) The specificity of serological reactions. Harvard University Press, Cambridge, MAGoogle Scholar
  27. Laverty R, Taylor KM (1969) Behavioral and biochemical effects of 2(2,6-dichloropheny- (amino)2-imidazodine HCl (ST 155) on the central nervous system. Br J Pharmacol. 35: 253–264PubMedGoogle Scholar
  28. Matteo RS, Pua EK, Khambatta HJ, Spector S (1977) Cerebrospinal fluid levels of d- tubocurarine in man. Anesthesiology. 46: 396–399PubMedCrossRefGoogle Scholar
  29. Michiels LJM, Heykants JJ, Knaeps AG, Jansen PAJ (1975) Radioimmunoassay of the neuroleptic drug pimozide. Life Sei. 16: 937–944CrossRefGoogle Scholar
  30. Paalzow L (1974) Analgesia produced by Clonidine in mice and rats. J Pharm Pharmacol. 26: 361–363PubMedCrossRefGoogle Scholar
  31. Peskar B, Spector S (1973 a) Serotonin: radioimmunoassay. Science. 179: 1340–1341Google Scholar
  32. Peskar B, Spector S (1973 b) Quantitative determination of diazepam in blood by radioimmunoassay. J Pharmacol Exp Ther. 186: 167–172Google Scholar
  33. Ranadive NS, Sehon AH (1967) Antibodies to serotonin. Can J Biochem. 45: 1701–1710PubMedCrossRefGoogle Scholar
  34. Reid JL, Wing LMH, Malthias CJ, Frankel HL, Neill E (1977) The central hypotensive effect of Clonidine. Clin Pharmacol Ther. 21: 375–381PubMedGoogle Scholar
  35. Schmitt H, Le Donarec JC, Petillot N (1974) Antinociceptive effects of some a-sympatho-mimetic agents. Neuropharmacology. 13: 389–394Google Scholar
  36. Smith TW, Haber E, Yeatman L, Butler VP Jr (1976) Reversal of advanced digoxin intoxication with Fab fragments of digoxin specific antibodies. N Engl J Med. 294: 797–800PubMedCrossRefGoogle Scholar
  37. Spector S (1971) Quantitative determination morphine in serum by radioimmunoassay. J Pharmacol Exp Ther. 178: 253–258PubMedGoogle Scholar
  38. Spector S, Parker CW (1970) Morphine: radioimmunoassay. Science. 168: 1347–1348PubMedCrossRefGoogle Scholar
  39. Spector S, Felix AM, Semenuk G, Finberg JPM (1978) Development of a specific radioimmunoassay for acetylcholine. J Neurochem. 30: 685PubMedCrossRefGoogle Scholar
  40. Strombom U (1975) Effects of low doses of catecholamine receptor agonists on exploration in mice. J Neural Transm. 37: 229–235PubMedCrossRefGoogle Scholar
  41. Struyker Boudier H, Van Rossum J (1972) Clonidine induced cardiovascular effects after stereotoxic application in the hypothalamus of rats. J Pharm Pharmacol. 24: 410–411PubMedCrossRefGoogle Scholar
  42. Struyker Boudier H, De Boer J, Smeets G, Lien EJ, Van Rossum J (1975) Structure activity relationships for central and peripheral alpha adrenergic activities of imidazoline de- rivitives. Life Sei. 17: 355–386CrossRefGoogle Scholar
  43. Tsoucaris-Kupfer D, Schmitt H (1972) Hypothermic effect of a-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs. Neuropharmacology. 11: 625–635PubMedCrossRefGoogle Scholar
  44. Wurzburger RJ, Miller RL, Boxenbaum HG, Spector S (1977) Radioimmunoassay of atro-pine in plasma. J Pharmacol Exp Ther. 203: 435–441PubMedGoogle Scholar
  45. Wurzburger RJ, Miller RL, Marcum EA, Colburn WA, Spector S (1980) A new radioimmunoassay for haloperidol; direct measurement of serum and striatal concentrations. J Pharmacol Exp Ther. 217: 757–763Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • S. Spector

There are no affiliations available

Personalised recommendations